Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrochemotherapy for Vulvar Paget's Disease and Precancerous Lesions
NCT06715592Phase 2Active, not recruiting
- Sponsor
- Policlinico Gemelli
- Start
- May 2023
- Primary completion
- Mar 2025
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bleomycin, Cisplatin micelle injection (HA132) in Paget's disease of the vulva (EMPD), vulvar intraepithelial neoplasia (VIN), vulvar carcinoma, sponsored by Policlinico Gemelli. Started May 2023; status: active, not recruiting.
02
Drugs
bleomycinCisplatin micelle injection (HA132)
03
Conditions
Paget's disease of the vulva (EMPD)vulvar intraepithelial neoplasia (VIN)vulvar carcinoma
Beyond the preview
Go deeper on NCT06715592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06715592.